Literature DB >> 17649951

[Biocompatibility of decellularized canine carotid artery allograft cross-linked by carbodiimide].

Chen-Guang Hao1, Da-Ping Yang, Hui Ma, Xue-Feng Han, Tie-Fang Guo.   

Abstract

UNLABELLED: OBJECTIVE Crosslink decellularized canine carotid artery allograft by EDC [1-3-(dimethylamino)propyl-3-ethylcarbodiimide methiodide] and evaluate the biocompatibility of it.
METHODS: Use the multi-step detergent-enzyme method to construct decellularized canine carotid artery allograft and cross-link it by EDC with the weight ratio of decellularized artery to EDC 1:1 and 1:2. Evaluate the biocompatibility of it by the cytotoxical MTT test and the rat subdermal bury test.
RESULTS: Decellularized canine carotid artery cross-linked by EDC has a lower degradation rate treated by collagenase type II, the result of MTT test show that the EDC cross-linked decellularized artery has no cytotoxity and the rat subdermal bury test show that crosslinking greatly enhance the ability of decellularize artery to resist the enzyme degradation and lower the immune reaction. The more the artery was cross-linked , the more effects it has.
CONCLUSIONS: Decellularized canine carotid artery cross-linked by EDC has fairly good biocompatibility and ability to resist the collagenase degradation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17649951

Source DB:  PubMed          Journal:  Zhonghua Zheng Xing Wai Ke Za Zhi        ISSN: 1009-4598


  1 in total

1.  Decellularized porcine pulmonary arteries cross-linked by carbodiimide.

Authors:  Xiu-Fang Xu; Hai-Ping Guo; Da Gong; Jin-Hui Ma; Zhi-Wei Xu; Ju-Yi Wan; Zhuo-Guang Wang; Zi-Fan Zhou; Wen-Bin Li; Yi Xin
Journal:  Int J Clin Exp Med       Date:  2013-08-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.